Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06289101 · ClinicalTrials.gov registry record · NA

text4FATHER R21: Social Media - Efficacy Trial

A NA study of Fathers and Mobile Health, sponsored by Johns Hopkins University.

Recruiting
Registry status
NA
Development phase
180
Enrollment target
1
Study location

NCT06289101 is a NA study of Fathers and Mobile Health that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 180 participants, below the 360-participant average among 4 other Fathers trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06289101, a NA study of Fathers and Mobile Health, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
NA
Development phase
180 participants
Enrollment target
1
Study location

Study Summary

This project will be the first to examine the efficacy of a text messaging intervention designed to recruit first-time fathers-to-be using social media across the U.S. to become involved during pregnancy through two months of postnatal age to support infant, mother, and father well-being.

Interventions

  • BEHAVIORAL text4FATHER

Study Locations (1)

Maryland

  • Johns Hopkins University - Baltimore

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2024-09-10
Est. Completion 2026-08
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT06289101

The ClinicalTrials.gov registry entry for NCT06289101 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 360-participant average among 4 other Fathers trials with a reported enrollment target (50% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Fathers appearing as the primary indexed condition, and to 1 intervention - of which text4FATHER is the first listed.

NCT06289101 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT06289101 about?

NCT06289101 is a clinical study titled "text4FATHER R21: Social Media - Efficacy Trial". This project will be the first to examine the efficacy of a text messaging intervention designed to recruit first-time fathers-to-be using social media across the U.S. to become involved during pregnancy through two months of postnatal age to support infant, mother, and father well-being.

What is the current status of trial NCT06289101?

This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2024-09-10. Estimated completion is 2026-08.

What conditions does trial NCT06289101 study?

This clinical trial studies the following conditions: Fathers, Mobile Health, Nuclear Family.

What interventions are being tested in trial NCT06289101?

The interventions under investigation include: text4FATHER (BEHAVIORAL).

Who is sponsoring clinical trial NCT06289101?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06289101 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fathers

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.